![Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde-2016-0026/asset/images/medium/figure1.gif)
Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery
![Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde-2016-0026/asset/images/medium/figure2.gif)
Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery
![SciELO - Brasil - A suppository-base-matrix tablet for time-dependent colon-specific delivery system A suppository-base-matrix tablet for time-dependent colon-specific delivery system SciELO - Brasil - A suppository-base-matrix tablet for time-dependent colon-specific delivery system A suppository-base-matrix tablet for time-dependent colon-specific delivery system](https://minio.scielo.br/documentstore/2175-9790/WQDM9cFqZYmVC9gnsn6wg6D/94f99287c9c05bb19349e2143deae624d7c5601e.jpg)
SciELO - Brasil - A suppository-base-matrix tablet for time-dependent colon-specific delivery system A suppository-base-matrix tablet for time-dependent colon-specific delivery system
![Modified and sustained release technologies: Sustained release tablets ( Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc. Modified and sustained release technologies: Sustained release tablets ( Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc.](https://www.spera-pharma.co.jp/wp-content/uploads/2019/02/formulation03en.jpg)
Modified and sustained release technologies: Sustained release tablets ( Matrix, Gastric retentive formulation) | SPERA PHARMA, Inc.
![New Matrix Tablet from Okra Gum: Effects of Method of Preparation and Gum Concentration on Tablet Properties New Matrix Tablet from Okra Gum: Effects of Method of Preparation and Gum Concentration on Tablet Properties](https://www.scirp.org/html/paperimages/36857_2.jpg)
New Matrix Tablet from Okra Gum: Effects of Method of Preparation and Gum Concentration on Tablet Properties
![Polymers | Free Full-Text | A Study of Compressibility, Compactability and Mucoadhesivity of Tableting Materials for Matrix Systems Based on Chitosan Polymers | Free Full-Text | A Study of Compressibility, Compactability and Mucoadhesivity of Tableting Materials for Matrix Systems Based on Chitosan](https://pub.mdpi-res.com/polymers/polymers-13-03636/article_deploy/html/images/polymers-13-03636-ag.png?1634976408)
Polymers | Free Full-Text | A Study of Compressibility, Compactability and Mucoadhesivity of Tableting Materials for Matrix Systems Based on Chitosan
![Application of Ethylcellulose Coating to Hydrophilic Matrices: A Strategy to Modulate Drug Release Profile and Reduce Drug Release Variability | SpringerLink Application of Ethylcellulose Coating to Hydrophilic Matrices: A Strategy to Modulate Drug Release Profile and Reduce Drug Release Variability | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1208%2Fs12249-014-0128-5/MediaObjects/12249_2014_128_Fig2_HTML.gif)
Application of Ethylcellulose Coating to Hydrophilic Matrices: A Strategy to Modulate Drug Release Profile and Reduce Drug Release Variability | SpringerLink
![Polymers | Free Full-Text | Drug-Polymers Composite Matrix Tablets: Effect of Hydroxypropyl Methylcellulose (HPMC) K-Series on Porosity, Compatibility, and Release Behavior of the Tablet Containing a BCS Class I Drug Polymers | Free Full-Text | Drug-Polymers Composite Matrix Tablets: Effect of Hydroxypropyl Methylcellulose (HPMC) K-Series on Porosity, Compatibility, and Release Behavior of the Tablet Containing a BCS Class I Drug](https://pub.mdpi-res.com/polymers/polymers-14-03406/article_deploy/html/images/polymers-14-03406-sch001.png?1661235211)
Polymers | Free Full-Text | Drug-Polymers Composite Matrix Tablets: Effect of Hydroxypropyl Methylcellulose (HPMC) K-Series on Porosity, Compatibility, and Release Behavior of the Tablet Containing a BCS Class I Drug
![Pharmaceutical Matrix Forming Excipients: Overview, Types, and Selection Criteria | PharmaCentral | Materials and Knowledge Platform Pharmaceutical Matrix Forming Excipients: Overview, Types, and Selection Criteria | PharmaCentral | Materials and Knowledge Platform](https://pharmacentral.com/wp-content/uploads/2021/11/matrix-tablets.jpg)
Pharmaceutical Matrix Forming Excipients: Overview, Types, and Selection Criteria | PharmaCentral | Materials and Knowledge Platform
![Sustained Release Matrix Tablet of Theophylline & Etophylline : Khan, Mohd Azaz, Selvi, Senthil: Amazon.es: Libros Sustained Release Matrix Tablet of Theophylline & Etophylline : Khan, Mohd Azaz, Selvi, Senthil: Amazon.es: Libros](https://m.media-amazon.com/images/I/71uDUd0ySVL._AC_UF1000,1000_QL80_.jpg)
Sustained Release Matrix Tablet of Theophylline & Etophylline : Khan, Mohd Azaz, Selvi, Senthil: Amazon.es: Libros
![The effect of alcohol on ionizing and non-ionizing drug release from hydrophilic, lipophilic and dual matrix tablets - Pharma Excipients The effect of alcohol on ionizing and non-ionizing drug release from hydrophilic, lipophilic and dual matrix tablets - Pharma Excipients](https://www.pharmaexcipients.com/wp-content/uploads/2019/12/Dissolution-profiles-of-lipophilic-F1-and-hydrophilic-F2-formulation.jpg)
The effect of alcohol on ionizing and non-ionizing drug release from hydrophilic, lipophilic and dual matrix tablets - Pharma Excipients
![Pharmaceutical Matrix Forming Excipients: Overview, Types, and Selection Criteria | PharmaCentral | Materials and Knowledge Platform Pharmaceutical Matrix Forming Excipients: Overview, Types, and Selection Criteria | PharmaCentral | Materials and Knowledge Platform](https://pharmacentral.com/wp-content/uploads/2021/11/pharmacentral-matrix-formers-770x277.jpg)
Pharmaceutical Matrix Forming Excipients: Overview, Types, and Selection Criteria | PharmaCentral | Materials and Knowledge Platform
![Design of Extended Release Matrix Tablet of Tramadol Hydrochloride / 978-613-9-89570-0 / 9786139895700 / 6139895707 Design of Extended Release Matrix Tablet of Tramadol Hydrochloride / 978-613-9-89570-0 / 9786139895700 / 6139895707](https://images.our-assets.com/cover/2000x/9786139895700.jpg)